Entera Bio (ENTX)
(Delayed Data from NSDQ)
$2.51 USD
+0.17 (7.26%)
Updated May 14, 2024 04:00 PM ET
After-Market: $2.43 -0.08 (-3.19%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Entera Bio Ltd falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -8.89 | -13.07 | -12.19 | -9.98 | -10.80 |
Depreciation/Amortization & Depletion | 0.06 | 0.06 | 0.05 | 0.23 | 0.24 |
Net Change from Assets/Liabilities | -0.20 | -1.84 | 1.41 | -0.35 | 0.69 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.72 | 2.34 | 1.66 | -0.31 | 0.95 |
Net Cash From Operating Activities | -7.31 | -12.50 | -9.06 | -10.42 | -8.92 |
Property & Equipment | -0.02 | -0.05 | -0.02 | -0.05 | -0.04 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 4.00 |
Other Investing Activities | 0.00 | -0.06 | 0.00 | -0.03 | -0.01 |
Net Cash from Investing Activities | -0.02 | -0.10 | -0.02 | -0.09 | 3.95 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 6.61 | 0.01 | 25.38 | 0.87 | 12.77 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | -0.14 | -0.11 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.58 | 0.00 | 0.00 | 3.19 | 0.00 |
Net Cash from Financing Activities | 6.04 | 0.01 | 25.38 | 3.92 | 12.65 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -1.29 | -12.59 | 16.30 | -6.59 | 7.68 |
Cash at Beginning of Period | 12.38 | 24.96 | 8.66 | 15.19 | 7.51 |
Cash at End of Period | 11.09 | 12.38 | 24.96 | 8.59 | 15.19 |
Diluted Net EPS | -0.31 | -0.45 | -0.47 | -0.55 | -0.89 |
Fiscal Year End for Entera Bio Ltd falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -8.89 | -6.89 | -4.52 | -2.19 |
Depreciation/Amortization & Depletion | NA | 0.06 | 0.04 | 0.03 | 0.01 |
Net Change from Assets/Liabilities | NA | -0.20 | 0.78 | 0.34 | 0.05 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 1.72 | 1.38 | 0.98 | 0.51 |
Net Cash From Operating Activities | NA | -7.31 | -4.69 | -3.17 | -1.61 |
Property & Equipment | NA | -0.02 | -0.01 | -0.01 | -0.01 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.02 | -0.01 | -0.01 | -0.01 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 6.61 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.58 | 0.01 | 0.01 | 0.00 |
Net Cash from Financing Activities | NA | 6.04 | 0.01 | 0.01 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -1.29 | -4.70 | -3.18 | -1.62 |
Cash at Beginning of Period | NA | 12.38 | 12.38 | 12.38 | 12.38 |
Cash at End of Period | NA | 11.09 | 7.68 | 9.20 | 10.76 |
Diluted Net EPS | -0.05 | -0.07 | -0.08 | -0.08 | -0.08 |